• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病理分期为N1的非小细胞肺癌的预后生物标志物研究

Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer.

作者信息

Komaki R, Milas L, Ro J Y, Fujii T, Perkins P, Allen P, Sikes C R, Mountain C F, Ordonez N G

机构信息

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

出版信息

Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):787-96. doi: 10.1016/s0360-3016(97)00898-5.

DOI:10.1016/s0360-3016(97)00898-5
PMID:9531362
Abstract

PURPOSE

The prognostic influence of 6 biomarkers correlated to histologic subtypes of non-small cell lung cancer (NSCLC) on loco-regional control, overall survival, disease-free survival (DFS), and distant disease control (DDC) rates, all measured at 5 years, were examined.

MATERIALS & METHODS: Cell blocks from the primary tumors of 137 patients with pathologically staged N1 NSCLC at MDACC were analyzed by 6-biomarker status correlated to histological subtypes and their outcomes.

RESULTS

The ranges of biomarker values were as follows: apoptotic index, 0.2-2.8%; mitotic index, 0-1.8%; the proportion of cells in S+G2M, 3-36%; p53 status, 0-100%; Ki-67, 0-9.3%; DNA index, 1.0-2.74. Subtypes of 137 cases from the postoperative pathology specimen showed that 74 patients had squamous carcinoma and 63 patients had adenocarcinoma. Mean and median lengths of follow-up were 4.21 years and 2.43 years, respectively. Patients with squamous cell carcinoma (SCC) had a better 5-year survival (p = 0.006), DFS (p = 0.002), and distant metastasis control (p = 0.002) than patients with adenocarcinoma (AC). Among patients with AC, the DNA index was a significant predictor of 5-year DFS (p = 0.02), DDC rate (p = 0.04), and local-regional control (p < 0.05). Higher apoptosis (p = 0.03) and mitosis indices (p = 0.03) were also univariate predictors of increased distant disease among patients with AC. Multivariate analysis of patients with AC revealed that the DNA index and Ki-67 were the only significant independent predictors of distant metastasis (p < 0.04 and p < 0.02, respectively) and DFS (p < 0.04 for both). Among patients with SCC, univariate analysis showed that S+G2M proportion (p < 0.05) and Ki-67 levels (p < 0.02) were significant predictors for local-regional control; for SC, multivariate analysis showed that only mitosis was a significant predictor in this case for overall survival (p < 0.04).

CONCLUSION

Spontaneous apoptotic index and Ki-67 were significantly higher in SC than in AC. Patients with SC had less distant metastasis better DFS and overall survival than those with AC. Multivariate analysis revealed that DNA index and Ki-67 status were significant predictors for DDC and DFS in patients with AC, but only mitotic index was a significant predictor of overall survival for patients with SCC.

摘要

目的

研究6种与非小细胞肺癌(NSCLC)组织学亚型相关的生物标志物对局部区域控制、总生存期、无病生存期(DFS)和远处疾病控制(DDC)率的预后影响,所有指标均在5年时进行测量。

材料与方法

对MDACC的137例病理分期为N1期NSCLC患者的原发肿瘤细胞块进行分析,根据与组织学亚型相关的6种生物标志物状态及其结果进行分析。

结果

生物标志物值的范围如下:凋亡指数,0.2 - 2.8%;有丝分裂指数,0 - 1.8%;S + G2M期细胞比例,3 - 36%;p53状态,0 - 100%;Ki - 67,0 - 9.3%;DNA指数,1.0 - 2.74。术后病理标本的137例病例的亚型显示,74例为鳞状细胞癌,63例为腺癌。平均随访时间和中位随访时间分别为4.21年和2.43年。鳞状细胞癌(SCC)患者的5年生存率(p = 0.006)、DFS(p = 0.002)和远处转移控制率(p = 0.002)均优于腺癌(AC)患者。在AC患者中,DNA指数是5年DFS(p = 0.02)、DDC率(p = 0.04)和局部区域控制(p < 0.05)的显著预测指标。较高的凋亡(p = 0.03)和有丝分裂指数(p = 0.03)也是AC患者远处疾病增加的单因素预测指标。对AC患者的多因素分析显示,DNA指数和Ki - 67是远处转移(分别为p < 0.04和p < 0.02)和DFS(两者均为p < 0.04)的唯一显著独立预测指标。在SCC患者中,单因素分析显示S + G2M期比例(p < 0.05)和Ki - 67水平(p < 0.02)是局部区域控制的显著预测指标;对于SCC,多因素分析显示在这种情况下只有有丝分裂是总生存期的显著预测指标(p < 0.04)。

结论

SCC患者的自发凋亡指数和Ki - 67显著高于AC患者。SCC患者的远处转移较少,DFS和总生存期均优于AC患者。多因素分析显示,DNA指数和Ki - 67状态是AC患者DDC和DFS的显著预测指标,但只有有丝分裂指数是SCC患者总生存期的显著预测指标。

相似文献

1
Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer.病理分期为N1的非小细胞肺癌的预后生物标志物研究
Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):787-96. doi: 10.1016/s0360-3016(97)00898-5.
2
Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer.凋亡和有丝分裂作为病理分期为N1的非小细胞肺癌的预后因素
Int J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):601-5. doi: 10.1016/s0360-3016(96)00351-3.
3
Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.CHD1L的过表达与肺腺癌转移呈正相关,并预示患者预后不良。
Oncotarget. 2015 Oct 13;6(31):31181-90. doi: 10.18632/oncotarget.5070.
4
Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.HAb18G/CD147 的表达及其定位与非小细胞肺癌的进展和不良预后相关。
Pathol Res Pract. 2013 Jun;209(6):345-52. doi: 10.1016/j.prp.2013.02.015. Epub 2013 Mar 25.
5
Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.在完全切除的IIA-IIIA期非小细胞肺癌患者中,肿瘤囊外扩展是一个有力的预后因素。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11268-77. eCollection 2015.
6
Clinical significance of IGF1R expression in non-small-cell lung cancer.IGF1R 表达在非小细胞肺癌中的临床意义。
Clin Lung Cancer. 2012 Mar;13(2):136-42. doi: 10.1016/j.cllc.2011.10.006. Epub 2011 Dec 1.
7
Evidence for apoptosis in non-small cell lung carcinoma. Relationship with cell kinetics and prognosis.非小细胞肺癌中细胞凋亡的证据。与细胞动力学及预后的关系。
Anal Quant Cytol Histol. 1999 Jun;21(3):240-4.
8
Prognostic value of chromosomal imbalances in squamous cell carcinoma and adenocarcinoma of the lung.染色体不平衡在肺鳞癌和腺癌中的预后价值。
Ann Thorac Surg. 2011 Sep;92(3):1038-43. doi: 10.1016/j.athoracsur.2011.04.052.
9
Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer.Ki-67表达与I期非小细胞肺癌切除术后吸烟者的预后
Ann Thorac Surg. 2003 Jun;75(6):1727-32; discussion 1732-3. doi: 10.1016/s0003-4975(03)00119-x.
10
Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.肿瘤浸润淋巴细胞对完全切除的IIIA期(N2)非小细胞肺癌患者的预后价值
Oncotarget. 2016 Feb 9;7(6):7227-40. doi: 10.18632/oncotarget.6979.

引用本文的文献

1
Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC).非小细胞肺癌(NSCLC)脑转移瘤切除术后组织学及全脑放疗的预后意义
Clin Exp Metastasis. 2015 Feb;32(2):143-9. doi: 10.1007/s10585-015-9699-0. Epub 2015 Jan 28.
2
Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis.肺癌中Ki-67表达与患者生存率:文献系统评价及荟萃分析
Br J Cancer. 2004 Dec 13;91(12):2018-25. doi: 10.1038/sj.bjc.6602233.
3
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.
Fas和Fas配体的表达状态可以预测肝细胞癌的复发。
Br J Cancer. 2000 Mar;82(6):1211-7. doi: 10.1054/bjoc.1999.1065.
4
Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma.细胞增殖和凋亡均显著预示肝细胞癌患者无病生存期缩短。
Br J Cancer. 1999 Oct;81(4):747-51. doi: 10.1038/sj.bjc.6690758.